Ed Harrigan

(Dr. Edmund Harrigan M.D.)

Currently holds positions in ACADIA Pharmaceuticals Inc, PhaseBio Pharmaceuticals Inc and Incyte Corp

Performance

Average Return

-12.5%

30 Days

8.2%

90 Days

15.1%

120 Days
Success Rate

50%

30 Days

68%

90 Days

82%

120 Days

Positions

Position Company Period
Independent Director ACADIA Pharmaceuticals Inc Nov. 30, 2015 -
Independent Director PhaseBio Pharmaceuticals Inc Dec. 31, 2018 -
Independent Director Incyte Corp Dec. 16, 2019 -
Independent Director Bellicum Pharmaceuticals Inc Feb. 23, 2018 - Dec. 19, 2019
Ed Harrigan's trades of PhaseBio Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-04 2020-12-03
B Purchase
6,000 +inf%
4.12
USD 24,720 		6,000 +inf% 4.12 USD 24,720
2020-08-14 2020-08-12
PS Planned sale
10,000 -15.3%
83.32
USD 833,200 		10,000 -15.3% 83.32 USD 833,200
2020-07-13 2020-07-13
PS Planned sale
10,000 -13.3%
93.40
USD 934,000 		10,000 -13.3% 93.40 USD 934,000
2020-06-15 2020-06-12
PS Planned sale
30,000 -28.5%
91.79
USD 2,753,700 		30,000 -28.5% 91.79 USD 2,753,700
// ... existing code ...